COMPANY NEWS IN BRIEF

J&J reports promising Ebola vaccine dataJohnson & Johnson (J&J) said on Monday its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal.The...
Klicken Sie hier, um weiterzulesen